CRS vs. EDIT

Last updated Jun 9, 2026

CRS (Carpenter Technology Corporation) and EDIT (Editas Medicine, Inc.) are both stocks. CRS operates in Metal Fabrication (Industrials), while EDIT operates in Biotechnology (Healthcare). Over the past 10 years, CRS returned 33.20%/yr vs -21.70%/yr for EDIT. At a 0.28 correlation, their price movements are largely independent.

Performance

CRS vs. EDIT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Carpenter Technology Corporation (CRS) and Editas Medicine, Inc. (EDIT). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, CRS achieves a 58.69% return, which is significantly higher than EDIT's 29.02% return. Over the past 10 years, CRS has outperformed EDIT with an annualized return of 33.20%, while EDIT has yielded a comparatively lower -21.70% annualized return.

CRS

• 1D: 3.20%
• 1M: 16.65%
• YTD: 58.69%
• 6M: 62.07%
• 1Y: 101.19%
• 3Y*: 115.41%
• 5Y*: 63.76%
• 10Y*: 33.20%

EDIT

• 1D: -2.40%
• 1M: -14.95%
• YTD: 29.02%
• 6M: 9.30%
• 1Y: 38.48%
• 3Y*: -35.09%
• 5Y*: -40.81%
• 10Y*: -21.70%

*Multi-year figures are annualized to reflect compound growth (CAGR)

CRS vs. EDIT - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
CRS Carpenter Technology Corporation	58.69%	86.23%	141.72%	94.48%	29.50%	2.66%	-39.44%	42.12%	-29.16%	43.40%
EDIT Editas Medicine, Inc.	29.02%	61.42%	-87.46%	14.21%	-66.59%	-62.13%	136.78%	30.15%	-25.97%	89.34%

Correlation

The correlation between CRS and EDIT is 0.15, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.15
Correlation (3Y) Calculated over the trailing 3-year period	0.25
Correlation (5Y) Calculated over the trailing 5-year period	0.28
Correlation (10Y) Calculated over the trailing 10-year period	0.28
Correlation (All Time) Calculated using the full available price history since Feb 4, 2016	0.28

The correlation between CRS and EDIT shifts across timeframes, from 0.15 (1 year) to 0.28 (10 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap CRS : $25.10B EDIT : $258.89M
EPS CRS : $9.51 EDIT : -$1.21
PS Ratio CRS : 8.30 EDIT : 6.66
PB Ratio CRS : 12.14 EDIT : 58.73
Total Revenue (TTM) CRS : $3.03B EDIT : $35.86M
Gross Profit (TTM) CRS : $900.50M EDIT : $35.86M
EBITDA (TTM) CRS : $745.50M EDIT : -$76.66M

Return for Risk

CRS vs. EDIT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CRS

CRS Risk / Return Rank: 90
CRS Sharpe Ratio Rank: 90
CRS Sortino Ratio Rank: 88
CRS Omega Ratio Rank: 87
CRS Calmar Ratio Rank: 93
CRS Martin Ratio Rank: 91

EDIT

EDIT Risk / Return Rank: 58
EDIT Sharpe Ratio Rank: 56
EDIT Sortino Ratio Rank: 63
EDIT Omega Ratio Rank: 59
EDIT Calmar Ratio Rank: 57
EDIT Martin Ratio Rank: 54

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CRS vs. EDIT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Carpenter Technology Corporation (CRS) and Editas Medicine, Inc. (EDIT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	CRS	EDIT	Difference
Sharpe ratio: Return per unit of total volatility	2.14	0.41	+1.73
Sortino ratio: Return per unit of downside risk	2.93	1.32	+1.60
Omega ratio: Gain probability vs. loss probability	1.37	1.15	+0.22
Calmar ratio: Return relative to maximum drawdown	5.33	0.65	+4.69
Martin ratio: Return relative to average drawdown	12.55	1.15	+11.40
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

CRS vs. EDIT - Sharpe Ratio Comparison

The current CRS Sharpe Ratio is 2.14, which is higher than the EDIT Sharpe Ratio of 0.41. The chart below compares the historical Sharpe Ratios of CRS and EDIT, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	CRS	EDIT	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	2.14	0.41	+1.73
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	1.38	-0.44	+1.81
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.68	-0.26	+0.94
Sharpe Ratio (All Time) Calculated using the full available price history	0.35	-0.20	+0.55

Drawdowns

CRS vs. EDIT - Drawdown Comparison

The maximum CRS drawdown since its inception was -84.68%, smaller than the maximum EDIT drawdown of -98.92%. Use the drawdown chart below to compare losses from any high point for CRS and EDIT.

Drawdown Indicators

	CRS	EDIT	Difference
Max Drawdown Largest peak-to-trough decline	-84.68%	-98.92%	+14.24%
Max Drawdown (1Y) Largest decline over 1 year	-19.08%	-59.88%	+40.80%
Max Drawdown (3Y) Largest decline over 3 years	-28.74%	-91.46%	+62.72%
Max Drawdown (5Y) Largest decline over 5 years	-41.86%	-98.66%	+56.80%
Max Drawdown (10Y) Largest decline over 10 years	-74.70%	-98.92%	+24.22%
Current Drawdown Current decline from peak	0.00%	-97.08%	+97.08%
Average Drawdown Average peak-to-trough decline	-27.25%	-62.60%	+35.35%
Ulcer Index Depth and duration of drawdowns from previous peaks	8.09%	33.66%	-25.57%

Volatility

CRS vs. EDIT - Volatility Comparison

The current volatility for Carpenter Technology Corporation (CRS) is 11.63%, while Editas Medicine, Inc. (EDIT) has a volatility of 31.99%. This indicates that CRS experiences smaller price fluctuations and is considered to be less risky than EDIT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	CRS	EDIT	Difference
Volatility (1M) Calculated over the trailing 1-month period	11.63%	31.99%	-20.36%
Volatility (6M) Calculated over the trailing 6-month period	33.18%	61.53%	-28.35%
Volatility (1Y) Calculated over the trailing 1-year period	47.75%	95.12%	-47.37%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	46.58%	94.12%	-47.54%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	48.83%	83.83%	-35.00%

Dividends

CRS vs. EDIT - Dividend Comparison

CRS's dividend yield for the trailing twelve months is around 0.16%, while EDIT has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
CRS Carpenter Technology Corporation	0.16%	0.25%	0.47%	1.13%	2.17%	2.74%	2.75%	1.61%	2.13%	1.41%	1.99%	2.38%
EDIT Editas Medicine, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials

Frequently Asked Questions

Can I hold both CRS and EDIT in my portfolio?

CRS and EDIT have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, CRS or EDIT?

EDIT has higher volatility (31.99%) compared to CRS (11.63%). In terms of maximum drawdown, CRS dropped -84.68% vs EDIT's -98.92%.

Which has better risk-adjusted returns?

CRS currently has the higher Sharpe Ratio (2.14 vs 0.41), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.